04:13 PM EDT, 06/05/2024 (MT Newswires) -- Badreddin Edris, Chief Operating Officer, on June 03, 2024, sold 20,000 shares in Springworks Therapeutics ( SWTX ) for $801,372. Following the Form 4 filing with the SEC, Edris has control over a total of 249,600 shares of the company, with 249,600 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1773427/000110465924068673/xslF345X03/tm2416457-1_4seq1.xml